Can Disease-Modifying Anti-Rheumatic Drugs Reduce the Risk of Developing Dementia in Patients with Rheumatoid Arthritis?
Sign Up to like & getrecommendations! Published in 2019 at "Neurotherapeutics"
DOI: 10.1007/s13311-019-00715-6
Abstract: Disease-modifying anti-rheumatic drugs (DMARDs) can reduce inflammation and slow progression of rheumatoid arthritis (RA). It remains unknown what impact DMARDs may have on dementia, where inflammation also plays a critical role in pathogenesis. Patients without… read more here.
Keywords: modifying anti; anti rheumatic; risk; disease modifying ... See more keywords
Developing a Dementia Platform Databank Using Multiple Existing Cohorts.
Sign Up to like & getrecommendations! Published in 2021 at "Yonsei medical journal"
DOI: 10.3349/ymj.2021.62.11.1062
Abstract: This study was conducted as a pilot project to evaluate the feasibility of building an integrate dementia platform converging preexisting dementia cohorts from several variable levels. The following four cohorts were used to develop this… read more here.
Keywords: status; dementia platform; platform; developing dementia ... See more keywords